| Fri, Oct 30, 2009 | | | NovaBay's Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis PR Newswire (Fri, Oct 30)
| | Wed, Oct 28, 2009 | | | NovaBay to Hold Conference Call to Review Aganocide Data Presented at the Infectious Diseases Society of America Meeting PR Newswire (Wed, Oct 28)
| | Thu, Oct 22, 2009 | | | NovaBay Pharmaceuticals to Present at 8th Annual Bio Investor Forum 2009 in San Francisco PR Newswire (Thu, Oct 22)
| | Mon, Oct 19, 2009 | | | NovaBay hires chief scientific officer at bizjournals.com (Mon, Oct 19)
| | | NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer PR Newswire (Mon, Oct 19)
| | Thu, Sep 24, 2009 | | | NovaBay Pharmaceuticals to Present at Maxim Group Growth Conference PR Newswire (Thu, Sep 24)
| | Mon, Sep 14, 2009 | | | NovaBay(R) Presents Data Confirming Its Aganocide(R) Compounds Are Effective In Killing Bacteria That Have Developed Multidrug-Resistance PR Newswire (Mon, Sep 14)
| | Thu, Sep 10, 2009 | | | NovaBay Launches Clinical Study for Non-Antibiotic Treatment of Impetigo, One of the Most Common Skin Infections PR Newswire (Thu, Sep 10)
| | Fri, Sep 4, 2009 | | | NOVABAY PHARMACEUTICALS, INC. Financials EDGAR Online Financials (Fri, Sep 4)
| | Thu, Sep 3, 2009 | | | NovaBay(R) Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference September 10, 2009 in New York City PR Newswire (Thu, Sep 3)
| | Wed, Aug 26, 2009 | | | NovaBay closes $2.45 million stock offering AP (Wed, Aug 26)
| | | NovaBay Pharmaceuticals Announces the Closing of Its $2.45 Million Registered Direct Offering of Common Stock and Warrants Marketwire (Wed, Aug 26)
| | Mon, Aug 24, 2009 | | | NovaBay Pharmaceuticals to Present New Pre-Clinical Data on Lead Anti-Infective Compound for use in Onychomycosis at the 2009 IDSA Annual Meeting PR Newswire (Mon, Aug 24)
| | Fri, Aug 21, 2009 | | | NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements an EDGAR Online (Fri, Aug 21)
| | | NovaBay Pharmaceuticals to Present New Data on Lead Anti-Infective Compound at the 2009 ICAAC Annual Meeting PR Newswire (Fri, Aug 21)
| | | NovaBay Pharmaceuticals, Inc. Announces Pricing of Registered Direct Offering of Common Stock and Warrants Marketwire (Fri, Aug 21)
| | Fri, Aug 14, 2009 | | | NovaBay Pharmaceuticals, Inc. Reports Second Quarter 2009 Financial Results PR Newswire (Fri, Aug 14)
| | | NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online (Fri, Aug 14)
| | Tue, Aug 4, 2009 | | | NOVABAY PHARMACEUTICALS, INC. Files SEC form 10-Q/A, Quarterly Report EDGAR Online (Tue, Aug 4)
| | Mon, Aug 3, 2009 | | | NOVABAY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online (Mon, Aug 3)
| Add NBY News to My Yahoo!:

| |
|